United States Biotechnology & Medical Research

Actuate Therapeutics Inc (ACTU)

Actuate Therapeutics Inc. recorded one insider purchase during the past ninety days. CEO Daniel M. Schmitt acquired 140,844 shares valued at approximately $50,000 on October 28, 2026. This activity follows a period of significant stock price decline. The company's most recent earnings report showed a minor beat, with the next disclosure scheduled for November 2026.
Ticker: ACTU Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Actuate Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SCHMITT DANIEL M President, CEO and Director Executive Director
Transaction date
Purchase
Price
226.70
Quantity 81,088 -7.5%
Value US$1,285,713
3.3
THOMSON TODD S Non-Executive Director Large shareholder
Transaction date
Sale
Price
265.44
Quantity 8,411 -4.3%
Value US$4,542,047
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 71,428 +57.1%
Value US$499,996
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 71,428 +57.1%
Value US$499,996
2.9
Kreis Leslie W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 71,428 +57.1%
Value US$499,996
3.3
THOMSON TODD S Non-Executive Director
Transaction date
Sale
Price
8.00
Quantity 18,750 -1.6%
Value US$150,000
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 New position
Value US$1,000,000
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 New position
Value US$1,000,000
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.9
Kreis Leslie W. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 New position
Value US$1,000,000
2.9
Kreis Leslie W. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-29 2026-10-28 B Purchase
SCHMITT DANIEL M

President, CEO and Director

Executive Director
81,088 -7.5%
226.70
US$1,285,713 		81,088 -7.5% 226.70 US$1,285,713
2026-01-07 2026-01-05 S Sale
3.3
THOMSON TODD S
Non-Executive Director Large shareholder
8,411 -4.3%
265.44
US$4,542,047 		8,411 -4.3% 265.44 US$4,542,047
2025-12-11 2025-12-11 PrS Proposed sale
Kairos Venture Partners II, L.P.

Affiliate
81,000
403.23
US$3,156,843 		81,000 403.23 US$3,156,843
2025-06-30 2025-06-27 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2025-06-30 2025-06-27 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2025-06-30 2025-06-27 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2024-08-16 2024-08-14 S Sale
3.3
THOMSON TODD S
Non-Executive Director
18,750 -1.6%
8.00
US$150,000 		18,750 -1.6% 8.00 US$150,000
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
125,000 New position
8.00
US$1,000,000 		125,000 New position 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
125,000 New position
8.00
US$1,000,000 		125,000 New position 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
125,000 New position
8.00
US$1,000,000 		125,000 New position 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
Explore more

More insider trading research around Actuate Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America